fda glp-1 warning news november 2025 Pharmacovigilance Assessment of Compounded Receptor Agonists: Insights From the Adverse Event Reporting System GLP-1 Weight-Loss Drug Demonstration Begins

Weight loss can include both fat mass and lean mass, which is why protein intake and resistance training are often discussed alongside GLP-1 use

Other topping options include: nuts, seeds, hemp hearts, sliced banana or strawberries, or nut butter

TRIUMPH-4 (Phase 3, 68 weeks) 12mg dose: 28.7% weight loss (~71 lbs / 32 kg average) 9mg dose: 26.4% weight loss (~64 lbs / 29 kg average) Patients also saw 76% reduction in knee osteoarthritis pain Blood pressure reduced by 14 mmHg on average Source: ClinicalTrials.gov (TRIUMPH-4, NCT05931367) The TRIUMPH Phase 3 program includes 4 trials studying retatrutide for obesity, type 2 diabetes, and cardiovascular outcomes

Other ID Program benefits include: Weekly health check-ins via questionnaire Provider review windows for short response times within business hours Personalized care with next-step dosing guidance sent through Ivims secure platform Support for nutrition, supplements, and muscle health as part of a complete care plan This level of responsiveness ensures your GLP-1 therapy adapts to your needs, whether youre adjusting your dose, changing medications, or optimizing your nutrition to preserve muscle mass